BSEResult18h ago · 23 Jul 2026, 01:04 pm

Financial Results along with the Limited Review Report of Novartis India Limited for the quarter ended June 30, 2026.

Novartis India Ltd · 500672

✦ AI SummaryResults

Novartis India Ltd has submitted its unaudited financial results for the quarter ended June 30, 2026, along with a limited review report from its statutory auditors.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Novartis India Ltd - 500672 - Financial Results Of Novartis India Limited For The Quarter Ended June 30, 2026.

Attachments (1)

📄

155fb5bd-acc7-4f62-b613-9ab3e5ae241e.pdf

pdf

Download →
View document text
Novartis India Limited Inspire BKC 7th Floor, Bandra Kurla Complex Bandra East, Mumbai 400051 Maharashtra, India Tel +91 22 50243000 Website: www.novartis.in CIN- L24200MH1947PLC006104 Email: india.investors@novartis.com July 23, 2026 The Secretary BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai - 400 001 Scrip Code: 500 672 Sub.: Integrated Filing (Financial) for the quarter ended June 30, 2026. Dear Sir/ Madam, Pursuant to Regulation 10(1A) and other applicable provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, SEBI Circular No. SEBI/HO/CFD/CFD-PoD2/CIR/P/2024/185 dated December 31, 2024, read with BSE Circular No. 20250102-4 and NSE Circular No. NSE/CML/2025/02 dated January 02, 2025, we are submitting herewith the Unaudited Financial Results for the quarter ended June 30, 2026 along with the Limited Review Report issued by the Statutory Auditors of the Company (Annexure I & II) and other disclosures as required under the Integrated Filing (Financial) for the quarter ended June 30, 2026. This is for your information and records. Thanking you, Yours faithfully, For Novartis India Limited Chandni Maru Company Secretary and Compliance Officer A60291 Encl.: as above Integrated Filing (Financial) for the quarter ended June 30, 2026. A. Statement on Deviation or Variation for Proceeds of Public Issue, Rights Issue, Preferential Issue, Qualified Institutions Placement etc.: Not Applicable. C. Disclosure of Outstanding Default on Loans and Debt Securities: - Not Applicable. Sr Particulars Amount No. (INR) 1. Loans / revolving facilities like cash credit from banks / financial institutions A. Total amount outstanding as on date NIL B. Of the total amount outstanding, amount of default as NIL on date 2. Unlisted debt securities i.e. NCDs and NCRPS A. Total amount outstanding as on date NIL B. Of the total amount outstanding, amount of default as NIL on date 3. Total financial indebtedness of the listed entity NIL including short-term and long-term debt D. Disclosure of Related Party Transactions (Applicable only for Half Yearly Filings (i.e. 02nd and 04th Quarter): Not Applicable. E. Statement on Impact of Audit Qualifications (For Audit Report with Modified Opinion) Submitted Along with Annual Audited Financial Results (Standalone and Consolidated Separately) (Applicable Only for Annual Filing i.e. 4th Quarter): Not Applicable.